Professor of Medicine, University Alabama
Nephrology
Dr. David G. Warnock, MD
|
|
Give Review
David Warnock is an expert in the field of Nephrology. He researched medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a top medical university. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. He has 1 awards "Elected Member". David Warnock is also published. He has 96 publications published. The lastest publication: "Time to treatment benefit for adult patients with Fabry disease receiving agalsidase : data from the Fabry Registry.'
Publications
- The role of cystatin-C in the confirmation of reduced glomerular filtration rate among the oldest old.
- Categories of Hospital-Associated Acute Kidney Injury: Time Course of Changes in Serum Creatinine Values.
- Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved Kidney function during agalsidase-beta therapy.
- Appendiceal tissue confirmation of Fabry's Disease.
- Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry Disease.
- The Furosemide Stress Test and Predicting AKI Outcomes.
- Urinary biomarker investigation in children with Fabry Disease using tandem mass spectrometry.
- Obesity, metabolic health, and the risk of end-stage renal Disease.
- Validation Study of Medicare Claims to Identify Older US Adults With CKD Using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
- Dietary Patterns and Risk of Death and Progression to ESRD in Individuals With CKD: A Cohort Study.
- Fabry Disease: Dose Matters.
- Incident ESRD and Treatment-Resistant Hypertension: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
- Metabolic Subtypes and Risk of Mortality in Normal Weight, Overweight, and Obese Individuals With CKD.
- Association between urinary albumin excretion and coronary heart Disease in black vs white adults.
- Prevalence of Apparent Treatment-Resistant Hypertension among Individuals With CKD.
- Cardiovascular risk factors in CKD associate With both ESRD and mortality.
- Genetic Disorders of potassium homeostasis.
- Association of duration of residence in the southeastern United States with chronic Kidney disease may differ by race: the REasons for Geographic and Racial Difference...
- The Amiloride-Sensitive Endothelial Sodium Channel and Vascular Tone.
- Healthy Behaviors, Risk Factor Control and Awareness of Chronic Kidney Disease.
- Comparison of absolute serum creatinine changes versus Kidney Disease: Improving Global Outcomes consensus definitions for characterizing stages of Acute kidney injury.
- Low Hemoglobin Levels and Recurrent Falls in U.S. Men and Women: Prospective Findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) Cohort.
- Geographic Variation in CKD Prevalence and ESRD Incidence in the United States: Results From the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
- Arrhythmias in Fabry Cardiomyopathy.
- Blood pressure indexes and end-stage renal disease risk in adults with chronic Kidney disease.
- Prospective safety study of bardoxolone methyl in patients with type 2 diabetes mellitus, end-stage renal Disease and peritoneal dialysis.
- Anti-?-galactosidase A antibody response to agalsidase beta treatment: Data from the Fabry Registry.
- Prevalence and prognosis of unrecognized myocardial infarctions in chronic Kidney disease.
- Association of Family History of ESRD, Prevalent Albuminuria, and Reduced GFR With Incident ESRD.
- Age-Specific Associations of Reduced Estimated Glomerular Filtration Rate with Concurrent Chronic Kidney Disease Complications.
- Albuminuria and racial disparities in the risk for ESRD.
- Chronic Kidney Disease and Risk of Death from Infection.
- Critical care nephrology: management of acid-base Disorders with CRRT.
- Age-Specific Association of Reduced Estimated Glomerular Filtration Rate and Albuminuria With All-Cause Mortality.
- Warfarin-related Nephropathy: another newly recognized complication of an old drug.
- Inflammation Biomarkers and Risk of All-Cause Mortality in the Reasons for Geographic and Racial Differences in Stroke Cohort.
- Development and Validation of a Self-assessment Tool for Albuminuria: Results From the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
- Association of Waist Circumference and Body Mass Index With All-Cause Mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.
- Incidence of stroke symptoms among adults with chronic Kidney disease: results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
- Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic Kidney disease.
- The Fabry cardiomyopathy: models for the cardiologist.
- Association of chronic Kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
- A distinct urinary biomarker pattern characteristic of female fabry patients that mirrors response to enzyme replacement therapy.
- Hemoglobin concentration and cognitive impairment in the Renal REasons for Geographic And Racial Differences in Stroke (REGARDS) Study.
- Prognostic indicators of renal Disease progression in adults with Fabry Disease: natural history data from the Fabry Registry.
- Associations of dietary fat with albuminuria and Kidney dysfunction.
- Introduction to the third annual rostand Vitamin D symposium.
- A roadmap for biomarker qualification.
- A validated Disease severity scoring system for Fabry Disease.
- Acute kidney injury in sepsis: questions answered, but others remain.
- Enzyme replacement therapy and Fabry Nephropathy.
- Introduction to Focus on Fabry nephropathy: biomarkers, progression, and Disease severity.
- Mineralocorticoid receptor blockers and chronic Kidney disease.
- The A563T variation of the renal epithelial Calcium channel TRPV5 among African Americans enhances Calcium influx.
- Correlates of anemia in American blacks and whites: the REGARDS Renal Ancillary Study.
- Introduction to Vitamin D Symposium, March 14, 2008.
- Racial differences in the competing risks of mortality and ESRD after Acute myocardial infarction.
- Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
- Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for Acute myocardial i...
- Membrane tension modulates the effects of apical cholesterol on the Renal epithelial sodium channel.
- WNK4-mediated regulation of Renal ion transport proteins.
- Antiproteinuric therapy and fabry nephropathy: sustained reduction of proteinuria in patients receiving enzyme replacement therapy With agalsidase-beta.
- Enzyme replacement therapy and Fabry Kidney disease: quo vadis?
- Prevalence and characteristics of a family history of end-stage renal Disease among adults in the United States population: Reasons for Geographic and Racial Differenc...
- Fabry Disease: guidelines for the evaluation and management of multi-organ system involvement.
- Survival advantage of black patients with kidney disease after Acute myocardial infarction.
- Racial differences in the prevalence of chronic Kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study.
- Chronic Kidney disease: a public health problem that needs a public health action plan.
- Recent progress in inherited Kidney diseases.
- Diagnosis and management of Kidney involvement in Fabry disease.
- Renal sodium handling: the role of the epithelial sodium channel.
- Towards a definition and classification of Acute kidney injury.
- Time-dependent associations between iron and mortality in hemodialysis patients.
- Prevalence of chronic Kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study: baseline resu...
- Delay in time to receipt of thrombolytic medication among Medicare patients with Kidney disease.
- Improvement of blood pressure With inhibition of the epithelial sodium channel in blacks With hypertension.
- Inclusion of albumin as a target in therapy guidelines: guidelines for chronic Kidney disease.
- Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule.
- Steroids and exogenous gamma-ENaC subunit modulate cation channels formed by alpha-ENaC in human B lymphocytes.
- Oxidative stress in hypertension and chronic Kidney disease: role of angiotensin II.
- Prevalence, treatment, and control of hypertension in Chronic hemodialysis patients in the United States.
- Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport.
- Interventional nephrology: work in progress.
- Familial hyperkalemic hypertension: phenotypic analysis in a large family With the WNK1 deletion mutation.
- Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors.
- Anionic phospholipids regulate native and expressed epithelial sodium channel (ENaC).
- ATP masks stretch activation of epithelial sodium channels in A6 distal nephron cells.
- Genetic forms of Renal potassium and magnesium wasting.
- Renal genetic Disorders related to K+ and Mg2+.
- Cognitive function in adults aging with fabry Disease: a case-control feasibility study using telephone-based assessments.
- Pathophysiology and Treatment of Resistant Hypertension: The Role of Aldosterone and Amiloride-Sensitive Sodium Channels.
- Association of inflammatory and endothelial cell activation biomarkers with Acute kidney injury after sepsis.
- Autophagy-lysosome pathway associated neuropathology and axonal degeneration in the brains of alpha-galactosidase A-deficient mice.
- High-sensitivity C-reactive protein and risk of sepsis.
- Time to treatment benefit for adult patients with Fabry Disease receiving agalsidase β: data from the Fabry Registry.
Schools
University Of California San Francisco School Of Medicine
National Institute Of Health
Conditions Treated
- Acute Kidney Failure
- Calcium Metabolism Disorders
- Chronic Kidney Diseases
- Congenital Cystic Kidney Disease
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Elected Member
Education
-
UCSF -
University of California San Francisco School of Medicine
Hospital
-
University of Alabama Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Paul W. Sanders, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rahim Kassamali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edgar A. Jaimes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vijay Mudunuri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Song C. Ong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zipporah Krishnasami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Orlando M. Gutierrez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Caroline B. Marshall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary B. Prendergast, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Azita Takeshian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James C. Harms, MD |
|
|
Dr. Rudolf P. Wuthrich, MD |
|
Dr. James R. Reed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Donald L. Quinn, PA
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brandi Wynne, MD
This Doctor is OpenDoctor Recommended.
|